Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.
ADP-ribosylation
DNA damage response
HPF1
PARP1
RNF114
SpyTag
antibodies
telomere
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
18 05 2023
18 05 2023
Historique:
received:
10
10
2022
revised:
14
02
2023
accepted:
27
03
2023
medline:
22
5
2023
pubmed:
29
4
2023
entrez:
28
4
2023
Statut:
ppublish
Résumé
PARP1, an established anti-cancer target that regulates many cellular pathways, including DNA repair signaling, has been intensely studied for decades as a poly(ADP-ribosyl)transferase. Although recent studies have revealed the prevalence of mono-ADP-ribosylation upon DNA damage, it was unknown whether this signal plays an active role in the cell or is just a byproduct of poly-ADP-ribosylation. By engineering SpyTag-based modular antibodies for sensitive and flexible detection of mono-ADP-ribosylation, including fluorescence-based sensors for live-cell imaging, we demonstrate that serine mono-ADP-ribosylation constitutes a second wave of PARP1 signaling shaped by the cellular HPF1/PARP1 ratio. Multilevel chromatin proteomics reveals histone mono-ADP-ribosylation readers, including RNF114, a ubiquitin ligase recruited to DNA lesions through a zinc-finger domain, modulating the DNA damage response and telomere maintenance. Our work provides a technological framework for illuminating ADP-ribosylation in a wide range of applications and biological contexts and establishes mono-ADP-ribosylation by HPF1/PARP1 as an important information carrier for cell signaling.
Identifiants
pubmed: 37116497
pii: S1097-2765(23)00240-X
doi: 10.1016/j.molcel.2023.03.027
pmc: PMC10205078
pii:
doi:
Substances chimiques
Histones
0
Poly (ADP-Ribose) Polymerase-1
EC 2.4.2.30
Chromatin
0
Antibodies
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1743-1760.e11Subventions
Organisme : NCI NIH HHS
ID : R01 CA262316
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R007195/1
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA207209
Pays : United States
Organisme : Cancer Research UK
ID : C35050/A22284
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101794
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 210634
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM133332
Pays : United States
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests E.J.L., H.D., J.J.B., T.C., and I.M. declare the following competing financial interests: Max-Planck-Innovation, the technology transfer center of the Max Planck Society, has licensed the antibodies AbD33204, AbD33205, AbD33644, AbD34251, AbD33641, and AbD43647 to Bio-Rad Laboratories.
Références
Org Biomol Chem. 2019 Jun 5;17(22):5460-5474
pubmed: 31112180
Cell. 2020 Nov 12;183(4):1086-1102.e23
pubmed: 33186521
Mol Cell. 2021 Jun 17;81(12):2640-2655.e8
pubmed: 34019811
Nat Commun. 2017 Dec 12;8(1):2055
pubmed: 29234005
Nature. 2021 Aug;596(7873):597-602
pubmed: 34408320
Nat Biotechnol. 2015 Apr;33(4):384-9
pubmed: 25774713
Mol Cell Proteomics. 2002 May;1(5):376-86
pubmed: 12118079
Nucleic Acids Res. 2011 Aug;39(15):6475-88
pubmed: 21576221
Cell Rep. 2018 Aug 28;24(9):2493-2505.e4
pubmed: 30157440
Elife. 2018 Feb 26;7:
pubmed: 29480802
Cancer Commun (Lond). 2021 Feb;41(2):187-191
pubmed: 33417305
Nat Struct Mol Biol. 2013 Apr;20(4):508-14
pubmed: 23474712
Nat Commun. 2021 Oct 8;12(1):5893
pubmed: 34625544
J Mol Biol. 2011 Oct 14;413(1):261-78
pubmed: 21856311
Cell Death Differ. 2013 Aug;20(8):1055-67
pubmed: 23645206
Nat Chem Biol. 2018 Feb 14;14(3):236-243
pubmed: 29443986
J Vis Exp. 2021 Jun 1;(172):
pubmed: 34152325
Cell Rep. 2021 Nov 2;37(5):109917
pubmed: 34731617
Nat Chem Biol. 2016 Dec;12(12):998-1000
pubmed: 27723750
Mol Cell. 2022 Jun 16;82(12):2315-2334
pubmed: 35271815
J Am Chem Soc. 2021 Jul 28;143(29):10847-10852
pubmed: 34264659
CRISPR J. 2022 Feb;5(1):123-130
pubmed: 35119294
Cell Rep. 2019 Jan 22;26(4):955-968.e3
pubmed: 30673617
Elife. 2021 Dec 07;10:
pubmed: 34874266
J Am Chem Soc. 2015 Mar 18;137(10):3558-64
pubmed: 25706250
Nucleic Acids Res. 2019 Dec 2;47(21):11250-11267
pubmed: 31566235
Mol Cell. 2021 Jan 21;81(2):340-354.e5
pubmed: 33450210
Science. 2009 Sep 4;325(5945):1240-3
pubmed: 19661379
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Mol Gen Genet. 1995 Jan 6;246(1):10-8
pubmed: 7823904
Mol Cell. 2018 Oct 4;72(1):162-177.e7
pubmed: 30244833
ACS Chem Biol. 2022 Apr 15;17(4):810-815
pubmed: 35312285
Science. 2011 Jun 17;332(6036):1443-6
pubmed: 21680843
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Sci Adv. 2022 Oct 7;8(40):eadd4253
pubmed: 36197986
J Am Chem Soc. 2021 Mar 3;143(8):3037-3042
pubmed: 33596067
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):E690-7
pubmed: 22366317
Genome Biol. 2003;4(5):P3
pubmed: 12734009
Mol Cell. 2021 Nov 4;81(21):4552-4567.e8
pubmed: 34551281
Genes Dev. 1998 Dec 15;12(24):3831-42
pubmed: 9869637
Nat Commun. 2020 Jul 7;11(1):3391
pubmed: 32636369
Nat Commun. 2021 Nov 18;12(1):6675
pubmed: 34795260
Cell. 2010 Oct 29;143(3):470-84
pubmed: 21029866
J Biol Chem. 2011 Dec 9;286(49):42470-42482
pubmed: 22027841
Methods Mol Biol. 2011;780:209-26
pubmed: 21870263
Nucleic Acids Res. 2017 Aug 21;45(14):8129-8141
pubmed: 28854736
Am J Hum Genet. 2018 Sep 6;103(3):431-439
pubmed: 30100084
Nature. 2020 Mar;579(7800):598-602
pubmed: 32028527
Biochemistry. 2017 Dec 5;56(48):6305-6316
pubmed: 29053245
Nature. 2008 Jan 3;451(7174):81-5
pubmed: 18172500
Mol Cell. 2017 Mar 2;65(5):932-940.e6
pubmed: 28190768
Mol Cell. 2017 May 18;66(4):503-516.e5
pubmed: 28525742
Science. 2016 Jul 1;353(6294):45-50
pubmed: 27256882
Nat Commun. 2014 Jul 21;5:4426
pubmed: 25043379
Nat Commun. 2020 Oct 15;11(1):5199
pubmed: 33060572
Nat Commun. 2019 Jul 4;10(1):2954
pubmed: 31273204
Elife. 2017 Jun 26;6:
pubmed: 28650317
Life Sci Alliance. 2021 Sep 3;4(11):
pubmed: 34479984
J Cell Biol. 2021 Apr 5;220(4):
pubmed: 33570569
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
Nat Struct Mol Biol. 2023 May;30(5):678-691
pubmed: 37106138
Elife. 2022 Apr 27;11:
pubmed: 35476036
Cell Chem Biol. 2021 Jun 17;28(6):813-824.e6
pubmed: 33529581
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Am J Hum Genet. 2018 Nov 1;103(5):817-825
pubmed: 30401461
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Mar 1;62(Pt 3):224-7
pubmed: 16511307
Mol Immunol. 2008 Nov;46(1):135-44
pubmed: 18722015
Nucleic Acids Res. 2019 Jul 2;47(W1):W171-W174
pubmed: 31106371
Mol Cell. 2016 May 5;62(3):432-442
pubmed: 27067600
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2121979119
pubmed: 35259019
Cell. 2014 Sep 25;159(1):108-121
pubmed: 25259924
Genes Dev. 2017 Jan 15;31(2):101-126
pubmed: 28202539
Cell. 2006 Jan 27;124(2):315-29
pubmed: 16439206